What You Should Know:
– Accenture has made a strategic investment in Ryght AI through its venture capital arm, aiming to modernize the sluggish clinical trial process. Ryght AI utilizes “agentic AI” and its proprietary…
Continue Reading
What You Should Know:
– Cellbyte, the AI-native platform that helps pharmaceutical companies accelerate drug launches, announces that it has raised $2.75 million in seed funding.
– The round was led by Frontline Ventures, with participation from…
Continue Reading
Sanofi and QuantHealth Team up to Advance AI-Powered Digital Twins and Clinical Trials Simulations to Accelerate Drug Development
QuantHealth, a pioneer in AI-driven clinical trial simulation, announced a strategic investment from Sanofi Ventures, the venture…
HRSA is scheduled to issue approvals to drugmakers by Oct. 15 for implementation of the pilot on Jan. 1, 2026.In July, the Health Resources and Services Administration announced the availability of a voluntary 340B…
Continue Reading
Healthcare and life sciences are entering a new phase of digital transformation, powered by the rise of agentic artificial intelligence. Unlike traditional AI tools that focus on prediction or classification, agentic AI combines decision-making…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Ronen Veksler, Co-Founder and CEO at Promise Bio. Promise Bio is an…
Continue Reading
Introduction
The healthcare industry is facing a significant policy shift that could fundamentally alter how hospitals access discounted medications. With critical deadlines rapidly approaching, the American Hospital Association (AHA) has intensified its opposition to a…
Strategic Transformation, Not Just Technology
This transformation involves more than just enhancing data infrastructure or implementing technological upgrades. Organizations at the forefront of this revolution understand that embracing the cloud calls for a strategic rethinking…
Noah Nasser, CEO at datma
In today’s precision medicine landscape, pharmaceutical companies and access teams face a critical challenge: understanding not just whether therapies work, but how they are accessed, adopted, and experienced by real-world…
Continue Reading
The Problem with Traditional Mental Health Assessment
Neuroscience technology company Brooklyn Health is leveraging artificial intelligence to address a critical flaw in neurology and psychiatry: the unreliable approach to mental health outcomes measurement. The startup’s…
